Cellectis

Last updated: August 01, 2025

André Choulika, CEO and Founder
André Choulika, CEO and Founder
France | Funding: $393.5M (+)

Website: http://www.cellectis.com/

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.